Skip to main content
. Author manuscript; available in PMC: 2018 Feb 15.
Published in final edited form as: Int J Cancer. 2016 Nov 14;140(4):764–776. doi: 10.1002/ijc.30494

Figure 2.

Figure 2

Multivariable-adjusted percent changes in the relative concentrations of plasma markers of insulin response and hormonal response (95% confidence intervals) across adherence categories of (A) the energy balance-related recommendations (BMI, physical activity and energy density), and (B) the combined plant/animal food/alcohol intake recommendations in the Nurses’ Health Study (women), 1990; and Health Professional Follow-up Study (men), 1994. 0–1 was the lowest or least adherent category (reference) while 3 was the highest or most adherent category. CPEP=C-peptide, TG/HDL=triglyceride/high density lipoprotein ratio. Estrone and estradiol were examined only among postmenopausal women not using exogenous hormones. Biomarker concentrations were adjusted for regular aspirin/NSAID use, age at blood draw, smoking status, physical activity, case-control status, postmenopausal status, postmenopausal hormone use, and chronic diseases/conditions. The following chronic diseases/conditions (yes=1/no=0) were included in the score: hypercholesterolemia, cancer, diabetes, high blood pressure, heart disease, and rheumatoid/other arthritis). The P-value for trend was the P-value of the combined recommendation score as a continuous variable adjusted for all covariates previously listed. Biomarker sample sizes were different: in women; CPEP, n=5,834; TG/HDL, n=3,826; estrone, n=1,217; and estradiol, n=1,254. In men; CPEP, n=3,955; and TG/HDL, n=3,575.

HHS Vulnerability Disclosure